Jiangsu Aoyang Health Industry Co., Ltd. (002172.SZ) manufactures and sells chemical fibers while engaging in health industry investments, including medical services, pharmaceutical distribution, and health management; its core products and services encompass viscose staple fibers, viscose fiber products, degradable fibers, functional fibers, textile raw materials, textiles, chemical products, steam heat supply, power production, pharmaceutical logistics, health management services, and medical treatments such as hyperbaric oxygen therapy. The company operates primarily in China through segments including chemical fibers, medical logistics, medical services featuring investments in hospitals and research centers, and health management via healthcare centers. Founded in 2001 and headquartered in Zhangjiagang, Jiangsu Province, it changed its name from Jiangsu Aoyang Technology Corporation Limited in September 2018 and listed on the Shenzhen Stock Exchange in 2007 as a subsidiary of Aoyang Group. Recent developments include a September 2025 share transfer agreement for Zhangjiagang Yuesheng Technology Partnership to acquire a 20% stake from Aoyang Group for approximately CNY 590 million, a planned 35 million yuan investment in the Jiangsu Aoyang Hospital for Geriatrics project with 105 beds via subsidiary Zhangjiagang Aoyang Geriatrics Hospital, a 17 million yuan capital injection into subsidiary Aoyang Nursing Home in August 2025, and property lease renewals for nursing operations.